Julia Wolf

ORCID: 0000-0003-0478-508X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood groups and transfusion
  • Platelet Disorders and Treatments
  • CAR-T cell therapy research
  • Multiple Myeloma Research and Treatments
  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Hemoglobinopathies and Related Disorders
  • Autoimmune Bullous Skin Diseases
  • Ethics and Legal Issues in Pediatric Healthcare
  • Biomedical Ethics and Regulation
  • T-cell and B-cell Immunology
  • Blood transfusion and management
  • Reproductive System and Pregnancy
  • Organ Donation and Transplantation
  • Complement system in diseases
  • Potassium and Related Disorders
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Retinal and Optic Conditions
  • Immune cells in cancer
  • Renal Diseases and Glomerulopathies
  • Nutrition and Health in Aging
  • Acute Lymphoblastic Leukemia research
  • Retinal Diseases and Treatments
  • Cancer-related gene regulation
  • Immune Response and Inflammation

Universitätsklinikum Erlangen
2025

At Bristol
2020-2025

University Hospitals Bristol NHS Foundation Trust
2017-2023

NHS Blood and Transplant
2021-2022

University Hospitals Bristol and Weston NHS Foundation Trust
2021

National Health Service
2020

Great Western Hospital
2019

University of Maryland, Baltimore County
2017

University of Bonn
2012

Vienna Biocenter
2001

β-Catenin is essential for E-cadherin–mediated cell adhesion in epithelial cells, but it also forms nuclear complexes with high mobility group transcription factors. Using a mouse mammary system, we have shown previously that conversion of cells to fibroblastoid phenotype (epithelial-mesenchymal transition) involves downregulation E-cadherin and upregulation β-catenin transcriptional activity. Here, demonstrate transient expression exogenous both arrested growth or caused apoptosis,...

10.1083/jcb.200104036 article EN The Journal of Cell Biology 2001-09-17

// Lucas A. Horn 1,* , Nicholas G. Ciavattone 2,* Ryan Atkinson 1 Netsanet Woldergerima Julia Wolf Virginia K. Clements Pratima Sinha Munanchu Poudel and Suzanne Ostrand-Rosenberg Department of Biological Sciences, University Maryland Baltimore County, Baltimore, MD, USA 2 Marlene Stewart Greenebaum Comprehensive Cancer Center, Maryland, * These authors contributed equally to this project Correspondence to: Ostrand-Rosenberg, email: Keywords : tumor-induced immune suppression, checkpoint...

10.18632/oncotarget.19865 article EN Oncotarget 2017-08-03

ABSTRACT Autologous stem cell transplant (ASCT) requires the collection of hematopoietic progenitor cells, commonly by apheresis (HPC‐A). These CD34+ cells can be mobilized using Granulocyte Colony Stimulating Factor (G‐CSF) only or chemomobilization plus G‐CSF. Both methods may additionally include Plerixafor. The emergence COVID‐19 led to recommendations for preferential G‐CSF mobilization. To assess impact this recommendation on HPC‐A harvesting, we analyzed data from NHS Blood and...

10.1002/jca.70012 article EN Journal of Clinical Apheresis 2025-03-02
Tom Bull Rory McCulloch Phillip L. R. Nicolson Andrew J. Doyle Rebecca Shaw and 95 more Alexander Langridge Zara Sayar David Tucker Michala Pettit Rita Perry William Thomas Catherine J. Page Ioana Whalley Tina Dutt Louise Garth Will Lester Richard J. Buka Maryam Subhan Victoria Ware Rachel Rayment Daniel Castle Astrid Etherington Luke Carter‐Brzezinski Jayne Peters Claire Corrigan Narind Sharma Gary Benson Sarah Challenor Thomas S. Skinner Rui Zhao Lyndsay A.G. McLeod‐Kennedy Kenneth Douglas Amy Knott Sophie Smith Julia Wolf Sophie A. Todd Vickie McDonald Alexandros Rampotas Christopher Dean Gina Sangha Sue Pavord Nicholas Denny Sarah Jaafar David P.T. McLaughlin Jennifer E. Ross Mamatha Karanth Sarah L. Beverstock Lynn Mansonso Samuel H. Burrows David P.T. McLaughlin Sudhir Tauro Amir Shenouda Benjamin Bailiff Daniel Kajita Joannes Hermans Harshita Goradia Emily M. Finan Sarah E. Alford Keir Pickard Brigit Greystoke Thomas Fail Asmaa Abdussalam Lara N. Roberts James B. Clark Natalie D. Heeney J. P. R. Young Jamie Maddox Swathy Srinath Jahanzeb Khawaja Jayne Parkes Samah Babiker Beverley J. Hunt Sarah L. Wheeldon Paul Kerr Molham Tahhan Mark H. Vickers Alexandra C. Pike Quentin A. Hill Nadreen Mustafa Azza Almaremi Emily Hughes Sean J.F. McGoldrick Eleana Loizou Izabela James Sara Boyce Isabel Farmer Murugaiyan Thanigaikumar Sarah L. Wheeldon Paul Kerr Katherine Wickenden Richard Gooding Kathryn Thornton Clare Kane Adam Cole J. D. M. Griffin Suzanne M. Docherty K Dixon Josephine Crowe Mathew Sheridan Corinne De Lord

Acute thrombotic thrombocytopenic purpura (TTP) is a life-threatening emergency and plasma exchange (PEX) the initial treatment shown to reduce acute mortality.To compare current practice in United Kingdom (UK) against standards set out 2012 British Society of Haematology guideline, better understand issues affecting prompt initiation PEX.The trainee research network HaemSTAR conducted retrospective nationwide review adults presenting UK hospitals with first episode TTP.Data on 148 patients...

10.1111/jth.15681 article EN cc-by-nc-nd Journal of Thrombosis and Haemostasis 2022-02-21

Summary Regulatory B (Breg) cells are potentially implicated in the pathogenesis of immune thrombocytopenia (ITP). We analysed a prospective cohort newly diagnosed steroid naïve ITP patients enrolled multicentre FLIGHT trial and found that numbers Bregs their peripheral blood were similar to healthy controls. In contrast, Breg significantly reduced treated with systemic immunosuppression (glucocorticoids or mycophenolate mofetil). also demonstrate glucocorticoid treatment impairs...

10.1111/bjh.19144 article EN cc-by British Journal of Haematology 2023-10-12

Extra-corporeal photopheresis (ECP) requires anticoagulation to prevent circuit clotting. Unfractionated heparin (UFH) is currently the only anticoagulant licensed for ECP system in use United Kingdom (UK). Acid citrate dextrose-A (ACD-A) preferred most other apheresis procedures. Anecdotal evidence suggested variability practice across UK with some providers using off-label ACD-A.We developed a survey together Photopheresis Society establish current practice.This was distributed all 17...

10.1111/tme.12836 article EN Transfusion Medicine 2021-12-02
Coming Soon ...